Yale Professor Says Hydroxychloroquine Could Save 100,000 Lives

A Yale professor claimed on Fox News that if the experimental anti-malaria drug Hydroxychloroquine was used to treat more coronavirus patients nationwide, it could save up to 100,000 lives.

Professor Harvey Risch, a professor of epidemiology for Yale’s School of Public Health, made the comments Tuesday on Laura Ingraham’s show, “The Ingraham Angle.” He explained that if the drug were used more widely and implemented as a “prophylactic” for emergency workers and medical personnel, as other countries have already done, then anywhere from 75,000 to 100,000 Americans could be saved.

Dr. Risch noted that “there are many doctors that I’ve gotten hostile remarks about saying that all the evidence is bad for it,” when such assertions are actually “not true at all.” He acknowledged that there is a “propaganda war” being waged against the drug purely because President Trump endorsed the drug early on, with his political opponents being determined to see any method supported by the president shot down rather than be implemented nationwide.

The evidence has always supported President Trump’s assertion that Hydroxychloroquine, originally used to treat malaria, is one of the most effective drugs against the Chinese coronavirus. Most recently, a study from the Henry Ford Health System in Southeast Michigan found that Hydroxychloroquine administration to coronavirus patients resulted in a “66 percent hazard ratio reduction.” The study concluded that, while more trials would be necessary, it was clear that “treatment with Hydroxychloroquine alone, and in combination with azithromycin, was associated with reduction in COVID-19 associated mortality.”

About Eric Lendrum

Eric Lendrum graduated from the University of California, Santa Barbara, where he was the Secretary of the College Republicans and the founding chairman of the school’s Young Americans for Freedom chapter. He has interned for Young America’s Foundation, the Heritage Foundation, and the White House, and has worked for numerous campaigns including the 2018 re-election of Congressman Devin Nunes (CA-22).

Photo: GettyImages

Content created by the Center for American Greatness, Inc. is available without charge to any eligible news publisher that can provide a significant audience. For licensing opportunities for our original content, please contact licensing@centerforamericangreatness.com.

Want news updates?

Sign up for our newsletter to stay up to date.